Degrading TBK1 to disarm VHL-deficient renal cancer.
Saved in:
| Title: | Degrading TBK1 to disarm VHL-deficient renal cancer. |
|---|---|
| Authors: | Kwon H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Bers AE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Parker Institute for Immunotherapy at the Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: david_barbie@dfci.harvard.edu. |
| Source: | Cell chemical biology [Cell Chem Biol] 2026 Apr 16; Vol. 33 (4), pp. 425-427. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41997114 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Degrading TBK1 to disarm VHL-deficient renal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kwon+H%22">Kwon H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Bers+AE%22">Bers AE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Barbie+DA%22">Barbie DA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Parker Institute for Immunotherapy at the Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: david&#95;barbie@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676030%22">Cell chemical biology</searchLink> [Cell Chem Biol] 2026 Apr 16; Vol. 33 (4), pp. 425-427. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676030 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2451-9448 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224519448%22">24519448 </searchLink><i>NLM ISO Abbreviation: </i>Cell Chem Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41997114 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.chembiol.2026.03.015 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 425 Titles: – TitleFull: Degrading TBK1 to disarm VHL-deficient renal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kwon H – PersonEntity: Name: NameFull: Bers AE – PersonEntity: Name: NameFull: Barbie DA IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 04 Text: 2026 Apr 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2451-9448 Numbering: – Type: volume Value: 33 – Type: issue Value: 4 Titles: – TitleFull: Cell chemical biology Type: main |
| ResultId | 1 |